Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)

Roskoski, R

Roskoski, R (corresponding author), Blue Ridge Inst Med Res, 3754 Brevard Rd,Suite 116,Box 19, Horse Shoe, NC 28742 USA.

PHARMACOLOGICAL RESEARCH, 2021; 165 ():

Abstract

Because dysregulation of protein kinases owing to mutations or overexpression plays causal roles in human diseases, this family of enzymes has become ......

Full Text Link